Renaud La Joie, PhD
Dr. La Joie originally trained in Neuroscience, Neuropsychology, and Neuroimaging in France before moving to UC Berkeley as a visiting scholar. He then joined UCSF as a post-doctoral fellow in 2016 and transitioned to a faculty position in 2021. His reseach combines multimodal neuroimaging techniques, fluid biomarkers, and neuropsychological measures to study the natural history of Alzheimer’s disease and other neurodegenerative diseases. He has established strong collaborations with neuropathologists to help bridge in vivo and post-mortem measures of brain pathology and guide a rigorous interpretation of biomarker data. His overarching goal is to understand the drivers of clinical heterogeneity and improve our ability to provide patients with a precise diagnosis and prognosis.
In 2022, Dr La Joie became the co-lead of the neuroimaging core for the NIA-funded Alzheimer’s disease research center (ADRC) and in 2023, he joined the faculty at the Global Brain Health Institute. He has been elected to the steering committee of multiple national and international organizations, including the Alzheimer’s Association’s Neuroimaging Professional Interest Area (2019-2023) and the ADRC Imaging Core Steering Committee (2024-2027).
Dr La Joie’s received multiple accolades for his work, including the young investigator award at the 2018 Human Amyloid Imaging Conference and the 2020 de Leon prize for best paper in neuroimaging of degenerative processes. In 2024, he received the Christopher Clark Award for his overarching work in human imaging of Alzheimer’s Disease.
In December 2024, Dr La Joie was appointed to the Edward and Pearl Fein Endowed Professorhip in Precision Care for Memory Disorders.